Results: The percentage of ALK-positive non-small cell lung cancer cases accounted for 10.7%, in which females and males was 17.5% and 6%, respectively (p=0.03), with the mean age of patients with ALK gene rearrangement younger than that of patients with non-rearrangement (53.3 years in comparison with 61.2 years) (p=0.002).